OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 27.00
-0.60 (-2.17%)
Dec 31, 2025, 2:31 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 7.1 billion as of December 31, 2025. Its market cap has decreased by -50.84% in one year.
Market Cap
7.10B
Enterprise Value
6.95B
Revenue
49.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.00
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 7.10B, a decrease of -57.90%. That is a compound annual growth rate of -6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 61.64B |
| Lin BioScience | 32.06B |
| Lumosa Therapeutics | 31.92B |
| Center Laboratories | 29.26B |